Phase 1 Study of Alvocidib (DSP-2033) in Combination with Cytarabine/Mitoxantrone (ACM) or Cytarabine/Daunorubicin (A+7+3) in Japanese Patients (Pts) with Acute Myeloid Leukemia (AML)-MedSci.cn

Phase 1 Study of Alvocidib (DSP-2033) in Combination with Cytarabine/Mitoxantrone (ACM) or Cytarabine/Daunorubicin (A+7+3) in Japanese Patients (Pts) with Acute Myeloid Leukemia (AML)

Morita, Y; Ikezoe, T; Ando, K; Onozawa, M; Yamane, T; Hosono, N; Kiguchi, T; Iwasaki, H; Miyamoto, T; Kasai, M; Sugimoto, S; Miyazaki, Y; Kizaki, M; Akashi, K

BLOOD, 2020; 136 ():

科室
- - 订阅+
  - 更多科室
工具
服务